Individuals Stopping Slimming Medications Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

Illustration of medical injection and scale
Weight management involves ongoing approaches.

Fresh analysis reveals that patients who discontinue popular slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who stop conventional diet and exercise plans.

Published data in a leading medical journal demonstrates that while obese individuals can lose a large proportion of their body weight while undergoing treatment, the mass comes back at an average rate of nearly a kilo each month after stopping.

"People using such medications must be informed of the danger of fast rebound weight gain when the medication concludes," warns expert Dr. Susan Jebb.

Such speed of regain suggests a reversion to starting mass in about a year and a half.

Weighing Therapies

The analysis, which reviewed 37 of trials involving thousands of patients, contrasted the results of these new drugs with other pills.

The team point out that individuals who shed pounds through lifestyle changes alone typically experience a more gradual weight regain—approximately 0.1 kg a month—once they finish.

Understanding the Quick Regain

Nutrition scientists suggest the mechanism of the drugs accounts for the accelerated rebound.

GLP-1 drugs copy a body's own chemical called GLP-1, which moderates feelings of fullness.

"Artificially providing the hormone levels several times higher than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' leads to hunger is uncontrolled, making overeating much more probable."

A Lifelong Disease?

Health authorities advise the injections for people with obesity-related health risks, alongside recommended lifestyle changes.

Many experts contend that, given the high risk of relapse, the treatment should be considered long-term.

This view is reinforced by pharmaceutical companies, who say that the results "underscore the long-term nature of obesity," comparing it to managing diseases like diabetes.

User Testimonies

People who have discontinued the medication report a powerful resurgence of hunger.

"I experienced a switch that goes on and you become ravenous," said a patient.

The struggle is worsened if individuals have not established sustainable lifestyle or habit changes during treatment.

Widespread Interest

Survey data suggest that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.

  • Adoption is greater among females compared to men.
  • The middle-aged age group shows the greatest usage rates.
  • Many access the medications through private healthcare rather than the NHS.

In conclusion, experts stress that while the jabs are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits hinges on combined lifestyle management.

Paul Williams
Paul Williams

A tech journalist and innovation strategist with over a decade of experience covering Canadian startups and digital policy.